Ginkgolides Meglumine Injection

DRUG3 trials

Sponsors

Jiangsu Kanion Pharmaceutical Co., Ltd

Conditions

Ischemic StrokePharmacokinetics

Phase 4

A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

CompletedNCT01958957

Jiangsu Kanion Pharmaceutical Co., LtdIschemic Stroke

Start: 2013-06-30End: 2014-10-31Updated: 2014-12-24

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

CompletedNCT02046031

Jiangsu Kanion Pharmaceutical Co., LtdIschemic Stroke

Start: 2014-02-28End: 2014-06-30Updated: 2014-07-15

A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam

CompletedNCT02233972

Jiangsu Kanion Pharmaceutical Co., LtdPharmacokinetics

Start: 2014-08-31Updated: 2014-10-20